Abstract:These data do not support the use of rectal misoprostol to reduce blood loss during LAVH. The pharmacoclinical effects of misoprostol in the uterus should be clarified.
“…Other studies have assessed the effects of using misoprostol pre‐operatively to reduce intra‐operative bleeding during hysterectomy performed as a method of treatment for symptomatic leiomyomas. Park et al . compared 49 women who received 400 μg of rectal misoprostol 1 h before having laparoscopic‐assisted vaginal hysterectomy (LAVH) for leiomyoma with 68 women who did not.…”
A single pre-operative dose of rectal misoprostol (400 μg) is a simple applicable method for reducing intra-operative blood loss and operative time in abdominal myomectomy.
“…Other studies have assessed the effects of using misoprostol pre‐operatively to reduce intra‐operative bleeding during hysterectomy performed as a method of treatment for symptomatic leiomyomas. Park et al . compared 49 women who received 400 μg of rectal misoprostol 1 h before having laparoscopic‐assisted vaginal hysterectomy (LAVH) for leiomyoma with 68 women who did not.…”
A single pre-operative dose of rectal misoprostol (400 μg) is a simple applicable method for reducing intra-operative blood loss and operative time in abdominal myomectomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.